• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄糖波动通过钠依赖性葡萄糖共转运蛋白 1(SGLT1)加速糖尿病小鼠的心脏损伤。

Glucose fluctuation accelerates cardiac injury of diabetic mice via sodium-dependent glucose cotransporter 1 (SGLT1).

机构信息

Department of General Medicine, The Third Affiliated Hospital of Shenzhen University, Shenzhen 518001, People's Republic of China.

Department of General Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, People's Republic of China.

出版信息

Arch Biochem Biophys. 2021 Sep 30;709:108968. doi: 10.1016/j.abb.2021.108968. Epub 2021 Jun 18.

DOI:10.1016/j.abb.2021.108968
PMID:34153296
Abstract

Recent studies have shown that blood glucose fluctuation is associated with complications of diabetes mellitus (DM). SGLT1 (sodium-dependent glucose cotransporter 1), is highly expressed in pathological conditions of heart, and is expressed in cardiomyocytes induced by high glucose. Herein, we constructed a diabetic mouse model with glucose fluctuation to investigate whether SGLT1 is involved in glucose fluctuation-induced cardiac injury. Echocardiography, histology examination, and TUNEL staining were performed to evaluate cardiac dysfunction and damage. To assess glucose fluctuation-induced oxidative stress, reactive oxygen species (ROS), malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH) levels were measured. To assess mitochondrial dysfunction, mitochondrial membrane potential (MMP), ATP content, mitochondrial respiratory chain complex activity, and expression of mitochondrial fusion and fission proteins were determined. The results indicated that diabetic mice with glucose fluctuation showed elevation of cardiac SGLT1 expression, left ventricular dysfunction, oxidative stress and mitochondrial dysfunction. Knockdown of SGLT1 could abrogate the effects of glucose fluctuation on cardiac injury. Thus, our study highlighted that SGLT1 plays an important role in glucose fluctuation induced cardiac injury through oxidative stress and mitochondrial dysfunction.

摘要

最近的研究表明,血糖波动与糖尿病(DM)的并发症有关。SGLT1(钠依赖性葡萄糖共转运蛋白 1)在心脏的病理条件下高度表达,并在高葡萄糖诱导的心肌细胞中表达。在此,我们构建了一种具有血糖波动的糖尿病小鼠模型,以研究 SGLT1 是否参与血糖波动诱导的心脏损伤。通过超声心动图、组织学检查和 TUNEL 染色来评估心脏功能障碍和损伤。为了评估血糖波动诱导的氧化应激,测量了活性氧(ROS)、丙二醛(MDA)、超氧化物歧化酶(SOD)、过氧化氢酶(CAT)和谷胱甘肽(GSH)的水平。为了评估线粒体功能障碍,测定了线粒体膜电位(MMP)、ATP 含量、线粒体呼吸链复合体活性以及线粒体融合和分裂蛋白的表达。结果表明,具有血糖波动的糖尿病小鼠表现出心脏 SGLT1 表达升高、左心室功能障碍、氧化应激和线粒体功能障碍。SGLT1 的敲低可以消除血糖波动对心脏损伤的影响。因此,我们的研究强调了 SGLT1 通过氧化应激和线粒体功能障碍在血糖波动诱导的心脏损伤中发挥重要作用。

相似文献

1
Glucose fluctuation accelerates cardiac injury of diabetic mice via sodium-dependent glucose cotransporter 1 (SGLT1).葡萄糖波动通过钠依赖性葡萄糖共转运蛋白 1(SGLT1)加速糖尿病小鼠的心脏损伤。
Arch Biochem Biophys. 2021 Sep 30;709:108968. doi: 10.1016/j.abb.2021.108968. Epub 2021 Jun 18.
2
Knockdown of SGLT1 prevents the apoptosis of cardiomyocytes induced by glucose fluctuation via relieving oxidative stress and mitochondrial dysfunction.敲低 SGLT1 可通过减轻氧化应激和线粒体功能障碍来防止葡萄糖波动诱导的心肌细胞凋亡。
Biochem Cell Biol. 2021 Jun;99(3):356-363. doi: 10.1139/bcb-2020-0491. Epub 2020 Dec 1.
3
Inhibition of SGLT1 protects against glycemic variability-induced cardiac damage and pyroptosis of cardiomyocytes in diabetic mice.SGLT1 抑制可预防糖尿病小鼠血糖波动诱导的心肌损伤和心肌细胞细胞焦亡。
Life Sci. 2021 Apr 15;271:119116. doi: 10.1016/j.lfs.2021.119116. Epub 2021 Jan 26.
4
Inhibition of SGLT1 Alleviates the Glycemic Variability-Induced Cardiac Fibrosis via Inhibition of Activation of Macrophage and Cardiac Fibroblasts.SGLT1 抑制通过抑制巨噬细胞和心肌成纤维细胞的激活减轻血糖变异性诱导的心脏纤维化。
Mol Cell Biol. 2022 Feb 17;42(2):e0028221. doi: 10.1128/MCB.00282-21. Epub 2021 Nov 29.
5
Effects of Sodium-Glucose Linked Transporter 2 Inhibition With Ertugliflozin on Mitochondrial Function, Energetics, and Metabolic Gene Expression in the Presence and Absence of Diabetes Mellitus in Mice.厄格列净对糖尿病及非糖尿病小鼠线粒体功能、能量代谢及代谢基因表达的影响。
J Am Heart Assoc. 2021 Jul 6;10(13):e019995. doi: 10.1161/JAHA.120.019995. Epub 2021 Jun 25.
6
Cardiac sodium-dependent glucose cotransporter 1 is a novel mediator of ischaemia/reperfusion injury.心脏钠依赖性葡萄糖协同转运蛋白 1 是缺血/再灌注损伤的一种新型介质。
Cardiovasc Res. 2019 Sep 1;115(11):1646-1658. doi: 10.1093/cvr/cvz037.
7
Akap1 deficiency exacerbates diabetic cardiomyopathy in mice by NDUFS1-mediated mitochondrial dysfunction and apoptosis.Akap1 缺乏通过 NDUFS1 介导的线粒体功能障碍和细胞凋亡加剧小鼠糖尿病心肌病。
Diabetologia. 2020 May;63(5):1072-1087. doi: 10.1007/s00125-020-05103-w. Epub 2020 Feb 19.
8
Cardiac ischemia-reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity.胰岛素抵抗状态下的心肌缺血再灌注损伤:SGLT1 而非 SGLT2 在饮食诱导肥胖中发挥代偿性保护作用。
Cardiovasc Diabetol. 2019 Jul 1;18(1):85. doi: 10.1186/s12933-019-0889-y.
9
Knockout of Na-glucose cotransporter SGLT1 mitigates diabetes-induced upregulation of nitric oxide synthase NOS1 in the macula densa and glomerular hyperfiltration.敲除钠-葡萄糖协同转运蛋白SGLT1可减轻糖尿病诱导的致密斑一氧化氮合酶NOS1上调及肾小球高滤过。
Am J Physiol Renal Physiol. 2019 Jul 1;317(1):F207-F217. doi: 10.1152/ajprenal.00120.2019. Epub 2019 May 15.
10
Transgenic knockdown of cardiac sodium/glucose cotransporter 1 (SGLT1) attenuates PRKAG2 cardiomyopathy, whereas transgenic overexpression of cardiac SGLT1 causes pathologic hypertrophy and dysfunction in mice.心脏钠/葡萄糖协同转运蛋白1(SGLT1)的转基因敲低可减轻PRKAG2心肌病,而心脏SGLT1的转基因过表达会导致小鼠病理性肥大和功能障碍。
J Am Heart Assoc. 2014 Aug 4;3(4):e000899. doi: 10.1161/JAHA.114.000899.

引用本文的文献

1
Cardiac sodium-glucose co-transporter 1 (SGLT1) contributes to heart failure in a mouse model of diabetic cardiomyopathy.心脏钠-葡萄糖协同转运蛋白1(SGLT1)在糖尿病性心肌病小鼠模型中会导致心力衰竭。
Basic Res Cardiol. 2025 Sep 11. doi: 10.1007/s00395-025-01136-7.
2
A Human Engineered Heart Tissue-Derived Lipotoxic Diabetic Cardiomyopathy Model Revealed Early Benefits of Empagliflozin.一种源自人工程心脏组织的脂毒性糖尿病心肌病模型揭示了恩格列净的早期益处。
Adv Sci (Weinh). 2025 Aug;12(30):e03173. doi: 10.1002/advs.202503173. Epub 2025 May 28.
3
Influence of fluctuations in fasting blood glucose on left ventricular function in patients with type 2 diabetes mellitus and coronary microcirculation dysfunction: a prospective cohort study.
空腹血糖波动对2型糖尿病合并冠状动脉微循环功能障碍患者左心室功能的影响:一项前瞻性队列研究。
Acta Diabetol. 2025 May 7. doi: 10.1007/s00592-025-02514-2.
4
Protective effect of antidiabetic drugs against male infertility: evidence from Mendelian randomization.抗糖尿病药物对男性不育的保护作用:孟德尔随机化研究证据
Diabetol Metab Syndr. 2025 Apr 28;17(1):140. doi: 10.1186/s13098-025-01700-0.
5
A meta-analysis of the relationship between glycaemic variability and the mortality of patients with heart failure.一项关于血糖变异性与心力衰竭患者死亡率之间关系的荟萃分析。
ESC Heart Fail. 2024 Jun;11(3):1305-1316. doi: 10.1002/ehf2.14627. Epub 2024 Jan 19.
6
Glucose fluctuations aggravate myocardial fibrosis via activating the CaMKII/Stat3 signaling in type 2 diabtetes.在2型糖尿病中,血糖波动通过激活CaMKII/Stat3信号通路加重心肌纤维化。
Diabetol Metab Syndr. 2023 Oct 28;15(1):217. doi: 10.1186/s13098-023-01197-5.
7
SGLT1: A Potential Drug Target for Cardiovascular Disease.SGLT1:心血管疾病的潜在药物靶点。
Drug Des Devel Ther. 2023 Jul 6;17:2011-2023. doi: 10.2147/DDDT.S418321. eCollection 2023.
8
Establishment of blood glucose control model in diabetic mice.糖尿病小鼠血糖控制模型的建立。
Int J Ophthalmol. 2022 Dec 18;15(12):1908-1914. doi: 10.18240/ijo.2022.12.03. eCollection 2022.
9
SGLT2 Inhibitors: New Hope for the Treatment of Acute Myocardial Infarction?SGLT2 抑制剂:急性心肌梗死治疗的新希望?
Am J Cardiovasc Drugs. 2022 Nov;22(6):601-613. doi: 10.1007/s40256-022-00545-6. Epub 2022 Aug 10.
10
Effects of SGLT2 Inhibitors beyond Glycemic Control-Focus on Myocardial SGLT1.SGLT2 抑制剂的血糖控制以外的作用-关注心肌 SGLT1。
Int J Mol Sci. 2021 Sep 12;22(18):9852. doi: 10.3390/ijms22189852.